GENE ONLINE|News &
Opinion
Blog

2026-04-02|

Mass General Brigham Researchers Develop HabitWorks App to Address Interpretation Bias in Anxiety and Depression

by GOAI
Share To

Researchers at Mass General Brigham have introduced a new smartphone application, HabitWorks, designed to address anxiety and depression by reshaping cognitive habits. The app focuses on altering interpretation bias, a common mental pattern where individuals tend to draw negative conclusions in uncertain or ambiguous situations. In a controlled trial, the app demonstrated potential in improving mental habits and enhancing cognitive function.

The study highlights HabitWorks’ approach to cognitive retraining as a key feature. By targeting interpretation bias, the app aims to help users develop more balanced thought patterns. Researchers tested the application in a structured environment and observed measurable improvements in participants’ mental health indicators. This development represents an effort to integrate digital tools into mental health care, addressing widespread conditions like anxiety and depression through accessible technology.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 2, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
[Illustrations] The Diversity Deficit in Oncology Trials: When Enrollment Logic No Longer Reflects Real-World Patients
2026-04-16
Japanese Researchers Identify Stem Cell Dynamics in Vocal Fold Tissue Maintenance and Repair
2026-04-16
Study Identifies Active Role of Skin Cells in Rabies Virus Replication and Transmission
2026-04-16
Contractor Fatality Halts Operations at ATEX Resources’ Valeriano Project in Chile
2026-04-15
Dual Inhibition of xCT and GGCT Induces Ferroptosis in Glioblastoma Cells
2026-04-15
Researchers Develop Method to Convert Ketones into Saturated Heterocycles for Pharmaceutical Applications
2026-04-15
Naturally Occurring Compounds Luteolin, Naringenin, and Scutellarin Identified as Potential Inhibitors of Breast Cancer-Linked Enzymes HDAC4 and HDAC8
2026-04-15
Scroll to Top